🔎 Trials Near Me

Home › NCT07145957

Does Undergoing a Prehabilitation Protocol Aimed at Optimizing Scapulothoracic Mobility and Strengthening Improve Internal Rotation After Reverse Shoulder Arthroplasty?

RecruitingObservational studyHealthy volunteers welcome

Does Undergoing a Prehabilitation Protocol Aimed at Optimizing Scapulothoracic Mobility and Strengthening Improve Internal Rotation After Reverse Shoulder Arthroplasty? A Randomized Controlled Trial

Who can join

Ages 40 to 80 · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria: • Patients aged 40-80

* Undergoing primary RSA for glenohumeral osteoarthritis or rotator cuff arthropathy
* Must be able to read and speak English
* Willing and able to attend a monthly therapy session and perform exercises at home for a minimum of 6 weeks before surgery
* Willing and able to participate in postoperative monitoring for a minimum of 2 years

Exclusion Criteria:

* Patients under the age of 40 and over the age of 80.
* Diagnosis of septic shoulder, fracture, or fracture sequelae, or tumor pathology of the ipsilateral shoulder
* Pre-existing hand, wrist, or elbow pathology that limits elbow flexion or extension, or forearm pronation or supination
* Planned to undergo synchronous procedure of the involved extremity (e.g., synchronous RSA and carpal tunnel release)
* Tendon transfer (e.g., Latissimus dorsi transfer) performed intraoperatively
* Patients without access to phone or email communication for at least 2 years after treatment
* Revision shoulder arthroplasty

About the study

Difficulty with internal rotation (IR) after reverse shoulder arthroplasty (RSA) is common. Current rehabilitation protocols may not optimize IR. The investigator's objective is to assess the impact of prehabilitation focused on IR strengthening and mobility on RSA outcomes. The investigators will perform a prospective, randomized control trial to achieve the specific aim: assessing range of motion, strength, patient-reported outcomes, and activities of daily living requiring internal rotation between control and prehabilitation cohorts, with the prehabilitation patients receiving 6 weeks of treatment.

What is being tested

Sponsor: University of Florida · Participants: 64 · Started: Nov 6, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT07145957

Locations in the U.S.

FloridaUniversity of Florida Department of Orthopaedics and Rehabilitation, Gainesville

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.